Company	Price	Valuation					Profitability					Cash & leverage					Quality				Rating
		P/E	P/B	P/S	EV / EBITDA	DCF upside	Gross margin	Operating margin	Net margin	ROE	ROIC	FCF yield	Debt / equity	Net debt / EBITDA	Interest coverage	Current ratio	Dividend yield	Piotroski (0-9)	Altman Z	Rating score (1-5)
BIM.PAthis companybioMérieux S.A.	€91.30	32.73×	3.17×	3.2×	12.91×	41.0%	52.6%	13.8%	9.8%	9.7%	9.1%	3.5%	0.11×	-0.11×	35.52×	2.39×	0.8%	7	5.92	4	A-
ABLD.PAABL Texcell Diagnostics S.A.	€2.38	-3.55×	0.19×	0×	-7.44×	329.5%	0.0%	0.0%	0.0%	-5.4%	-3.9%	-11.4%	0×	-9.13×	-9,331.09×	28.79×	0.0%	3	230.99	—	—
ALBIO.PABiosynex S.A.	€0.82	-0.19×	0.34×	0.12×	7.57×	-245.0%	-3.8%	-4.9%	-61.1%	-179.4%	-4.1%	-76.7%	1.9×	6.26×	-1.06×	1.94×	0.0%	1	0.8	1	D+
ALERS.PAEurobio Scientific S.A.	€26.35	51.81×	1.36×	1.48×	7.57×	118.7%	40.5%	9.1%	2.9%	2.6%	4.5%	2.5%	0.09×	-0.13×	7.73×	1.98×	0.0%	6	1.99	4	A-
ALKLH.PAKlea Holding	€0.16	31.29×	2.44×	3.04×	12.99×	-584.4%	44.2%	16.6%	10.3%	8.3%	8.7%	5.8%	0.19×	0.02×	4.33×	2.38×	0.0%	—	—	1	C-
ALNOV.PANovacyt S.A.	€0.42	-1.18×	1.18×	1.35×	-2.3×	-181.4%	38.7%	-64.6%	-114.2%	-99.9%	-31.3%	-32.7%	0.45×	1.06×	-19.39×	4.74×	0.0%	2	-1.38	2	C
Peer median	—	-0.19×	1.18×	1.35×	7.57×	-181.4%	38.7%	0.0%	0.0%	-5.4%	-3.9%	-11.4%	0.19×	0.02×	-1.06×	2.38×	0.0%	3	1.4	2	—